JPH0597690A - Composition having action to maintain ophthalmic function and to remit ophthalmic disease - Google Patents

Composition having action to maintain ophthalmic function and to remit ophthalmic disease

Info

Publication number
JPH0597690A
JPH0597690A JP3106637A JP10663791A JPH0597690A JP H0597690 A JPH0597690 A JP H0597690A JP 3106637 A JP3106637 A JP 3106637A JP 10663791 A JP10663791 A JP 10663791A JP H0597690 A JPH0597690 A JP H0597690A
Authority
JP
Japan
Prior art keywords
extract
action
composition
function
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3106637A
Other languages
Japanese (ja)
Inventor
Katsumichi Matsushige
繁 克 道 松
Umi Kouzan
山 海 洪
Suehito Yamagami
上 末 人 山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NISSEI MARINE KOGYO KK
Original Assignee
NISSEI MARINE KOGYO KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NISSEI MARINE KOGYO KK filed Critical NISSEI MARINE KOGYO KK
Priority to JP3106637A priority Critical patent/JPH0597690A/en
Publication of JPH0597690A publication Critical patent/JPH0597690A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE:To obtain the subject composition usable for food, drug, etc., and composed of a concentrate of carp internal organs, a ginseng extract, san-chi ginseng, pearl shell powder, etc. CONSTITUTION:The objective composition is composed of 5-15(wt.)% concentrate of carp internal organs, 3-10% ginseng extract, 5-15% san-chi ginseng, 10-30% pearl shell powder, 3-10% lamprey extract, 7-20% chrysanthemum flower extract, 10-30% Chinese matrimony vine extract, 3-10% Cassia trosa extract, 8-25% wheat embryo bud powder and 4-12% honey.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】この発明は眼の機能維持作用及び
眼疾患改善作用を有し、食料品や医薬品等の分野に利用
できる組成物に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a composition having an ocular function maintaining action and an eye disease improving action, which can be used in the fields of foods, pharmaceuticals and the like.

【0002】[0002]

【従来の技術】近年高齢者の急増と共に老化に伴って発
症する老年性疾患も著しい増加をみせており、水晶体の
焦点調節機能低下による老眼を始め、眼のかすみや充血
等が著しく増加しつつある。また、コンピュータやワー
ドプロセッサ等の普及に伴い眼精疲労や視力障害或は仮
性近視等の眼の障害が高齢者に限らずあらゆる年齢層に
おいて増加しているのが現状である。
2. Description of the Related Art In recent years, with the rapid increase in the number of elderly people, the number of senile diseases that develop with aging has also markedly increased, and presbyopia due to decreased focus control function of the crystalline lens, as well as blurring of the eyes and hyperemia, are increasing remarkably. .. Further, with the spread of computers and word processors, eye disorders such as asthenopia, visual acuity, and pseudo-myopia are increasing not only in the elderly but in all age groups.

【0003】[0003]

【発明が解決しようとする問題点】このような眼の障害
のうち、細菌等の感染症に起因する炎症には抗生剤や抗
炎症剤等有効な治療薬が既に存在しているが、老化によ
る内臓等の全身的な機能低下や目の酷使等に起因する機
能低下等によって生ずる眼の障害については有効な治療
薬が存在しないのが現状である。本発明はこのような現
状を打開するためになされたもので、老化や疲労などに
起因する眼の障害を除去し、眼の機能維持作用及び眼疾
患改善作用を有する組成物を提供することを目的とす
る。
Among such eye disorders, there are already effective therapeutic agents such as antibiotics and anti-inflammatory agents for inflammation caused by infectious diseases such as bacteria. At present, there is no effective therapeutic drug for eye disorders caused by systemic functional deterioration of internal organs and the like and functional deterioration due to overuse of the eyes. The present invention has been made in order to overcome such a situation, removes eye disorders caused by aging and fatigue, and provides a composition having an eye function maintaining action and an eye disease improving action. To aim.

【0004】[0004]

【発明の概要】上記目的を達成するために、本発明者ら
は東洋医学を基本に研究を重ねてきた。東洋医学では
「眼は内臓の窓」と言い表わされており、眼と内臓の関
連生は深く、内臓機能低下が眼の障害となって現われる
と考えられている。本発明者らはこのような前提に基づ
いて、内臓の機能が正常であれば眼の機能も正常に保た
れ、眼の機能を維持するためには内臓機能を改善するこ
とが不可欠であるとの知見に至り、本発明の組成物を開
発するに至ったものである。本発明の組成物は、 鯉内
臓濃縮物、高麗人参エキス、三七人参、真珠貝粉末、菊
花エキス、枸杞エキス、ハブ茶エキスを含有することを
基本的な特徴とする。またこれらに加えて八つ目鰻エキ
ス、小麦胚芽末或は蜂蜜を適宜含有させると更に効果が
大きいことが明かとなった。これら各成分の含有率は下
記の範囲とするのが望ましい。 鯉内臓濃縮物 :5wt%以上15wt%以下 高麗人参エキス:3wt%以上10wt%以下 三七人参 :5wt%以上15wt%以下 真珠貝粉末 :10wt%以上30wt%以下 八つ目鰻エキス:3wt%以上10wt%以下 菊花エキス :7wt%以上20wt%以下 枸杞エキス :10wt%以上30wt%以下 ハブ茶エキス :3wt%以上10wt%以下 小麦胚芽末 :8wt%以上25wt%以下 蜂 蜜 :4wt%以上12wt%以下 鯉内臓濃縮物は鯉の内臓を加熱し、濃縮して乾燥させた
ものである。また高麗人参エキス、菊花エキス、枸杞エ
キス、ハブ茶エキス、八つ目鰻エキスは各素材のエキス
分を水又はアルコールに抽出した後にこの抽出液を濃縮
して製造したものである。更に三七人参は三七人参を乾
燥して粉末化したものを用いる。真珠貝粉末はパールカ
ルシュームと呼ばれているもので文字どおり真珠貝を粉
末化したものである。上記各成分の構成及び効力を示せ
ば、次の通りである。鯉内臓濃縮物は、バランスのよい
アミノ酸を豊富に含有し、ビタミンA、B1、B2、
E、鉄、リンなどのミネラルを含有しており、精神安定
・清熱解毒等に効果がある。高麗人参(朝鮮人参)エキ
スは、サポニン(panaceneC15.)、ビタミンA、B1、B
2、C等を含有し、神経反射の短縮、条件反射の強化、
分析能力向上、疲労軽減、大脳の抑制、ストレスに対す
る抵抗力の強化、強壮作用、性機能の強化、心臓の収縮
力強化(心筋の代謝改善)、血糖の降下、消化吸収機能
の改善、貧血の改善等の効果を有している。三七人参
(田七人参)は、三七サポニン各種及びflavon配糖体を
含有し、止血、消腫、鎮痛、血液凝固時間短縮、血管収
縮、消炎等の効果を有する。真珠貝粉末は、炭酸カルシ
ューム、鉄、カリューム、マグネシューム、亜鉛、銅、
マンガン、コンキオリン蛋白等を含有し、精神(神経)
安定・清熱解毒・利尿・視神経の伝達を安定(網膜→視
覚野)化し、骨を丈夫にする効果がある。八ツメ鰻エキ
スは、ビタミンA、カルシューム・鉄・リンを含有し、
視力の低下防止、粘膜の強化、免疫力強化、細菌・ウイ
ルス感染防止等の作用を備えている。菊花エキスは、ad
enine、stachydrine、choline精油を含有し、疎散風
熱、明目、清熱解毒、平肝陽、消炎、利尿、降圧、抗菌
作用等を有している。枸杞エキスは、betaine、ビタミ
ンA・B1・B2・C・カルシューム、リン、鉄を含有
しており、補肝腎・生精血・明目・滋養・強壮、肝庇護
作用等の効果がある。ハブ茶エキスは、emodin、caroti
nを含有し、清肝明目、通便、消炎、降圧、抗真菌作用
等を有している。これらの素材を上記成分範囲で混合し
て服用した場合、著しい眼の機能維持効果があった。そ
の結果を実施例により示す。
SUMMARY OF THE INVENTION In order to achieve the above object, the present inventors have conducted research based on Oriental medicine. In the Oriental medicine, it is described as "the eye is a window of internal organs", and it is thought that the relationship between the eyes and internal organs is deep, and the decreased internal organ function appears as an eye disorder. Based on such a premise, the present inventors say that if the function of the internal organs is normal, the function of the eyes is also maintained normally, and it is indispensable to improve the internal function in order to maintain the function of the eyes. The present inventors have come to the findings of the above and have developed the composition of the present invention. The composition of the present invention is basically characterized by containing a carp viscera concentrate, ginseng extract, Radix Notoginseng, pearl clam powder, chrysanthemum extract, lacquer extract and hub tea extract. In addition to these, it was clarified that the eighth eel extract, wheat germ powder or honey was contained as appropriate to further increase the effect. The content of each of these components is preferably within the following range. Carp offal concentrate: 5 wt% or more and 15 wt% or less Korean ginseng extract: 3 wt% or more and 10 wt% or less 37 ginseng: 5 wt% or more and 15 wt% or less Pearl shell powder: 10 wt% or more and 30 wt% or less Eighth eel extract: 3 wt% or more 10 wt% or less Chrysanthemum extract: 7 wt% or more and 20 wt% or less Dusk extract: 10 wt% or more and 30 wt% or less Hub tea extract: 3 wt% or more and 10 wt% or less Wheat germ powder: 8 wt% or more and 25 wt% or less Honey: 4 wt% or more and 12 wt% or less Carp offal concentrate is obtained by heating, concentrating and drying carp offal. In addition, ginseng extract, chrysanthemum extract, halibut extract, hub tea extract, and eighth eel extract are produced by extracting the extract of each material with water or alcohol and then concentrating the extract. Furthermore, as Radix Notoginseng, dried Radix Notoginseng is used and powdered. Pearl shell powder is called pearl calcium and is literally a powder of pearl shell. The constitution and effect of each of the above components are as follows. Carp offal concentrate is rich in well-balanced amino acids and contains vitamins A, B1, B2,
Containing minerals such as E, iron and phosphorus, it is effective for mental stabilization and detoxification of clear heat. Ginseng extract is saponin (panacene C15.), Vitamins A, B1 and B.
Contains C, etc., shortens nerve reflex, enhances conditioned reflex,
Analytical ability improvement, fatigue reduction, cerebral suppression, stress resistance enhancement, tonic action, sexual function enhancement, heart contractility enhancement (myocardial metabolism improvement), blood glucose reduction, digestive absorption function improvement, anemia Has effects such as improvement. Radix Notoginseng (Tanachinin ginseng) contains various types of Radix Notoginseng saponin and flavon glycosides, and has effects such as hemostasis, anti-tumor, analgesia, shortening of blood coagulation time, vasoconstriction and inflammation. The pearl pearl powder is carbonate, calcium, iron, calcium, magnesium, zinc, copper,
Contains manganese, conchiolin protein, etc., mental (nerve)
Stable, clear heat detoxification, diuresis, stabilizing the transmission of the optic nerve (retinal → visual cortex), and has the effect of strengthening the bone. Yatsume Unagi Extract contains vitamin A, calcium, iron and phosphorus,
It has the effects of preventing visual loss, strengthening mucous membranes, strengthening immunity, and preventing bacterial and viral infections. Chrysanthemum extract is ad
It contains enine, stachydrine and choline essential oils, and has sensible heat, bright eyes, clear heat detoxification, Hira liver yang, anti-inflammatory, diuretic, antihypertensive and antibacterial action. The 杸 杞 extract contains betaine, vitamins A, B1, B2, C, calcium, phosphorus, and iron, and has effects such as supplemental kidney, raw sperm blood, clear eyes, nourishment, tonicity, and liver protection. Hub tea extract, emodin, caroti
Containing n, it has clear liver, bowel movement, anti-inflammatory, antihypertensive, antifungal action, etc. When these materials were mixed in the above component range and taken, there was a remarkable effect of maintaining the eye function. The results are shown by examples.

【0005】[0005]

【実施例】【Example】

<実施例1>既に老眼と診断された者8名について、下
記成分の組成物を練り固めて1粒340mgに打錠し、
症状に応じて1日3粒乃至8粒を投与し、その効果を確
認した。その結果を表1に示す。 (組成物) 鯉内臓濃縮物 :8.8wt% 高麗人参エキス:5.8wt% 三七人参 :8.8wt% 真珠貝粉末 :14.7wt% 八つ目鰻エキス:5.8wt% 菊花エキス :11.8wt% 枸杞エキス :17.6wt% ハブ茶エキス :5.8wt% 小麦胚芽末 :13.2wt% 蜂 蜜 :7.7wt%
<Example 1> For 8 persons who were already diagnosed with presbyopia, the composition of the following components was kneaded and compressed into tablets of 340 mg each,
Depending on the symptom, 3 to 8 tablets were administered daily and the effect was confirmed. The results are shown in Table 1. (Composition) Carp offal concentrate: 8.8 wt% Korean ginseng extract: 5.8 wt% Radix Notoginseng: 8.8 wt% Pearl shell powder: 14.7 wt% Eighth eel extract: 5.8 wt% Chrysanthemum extract: 11.8 wt% Pleurotus guttata extract: 17.6 wt% Hub tea extract: 5.8 wt% Wheat germ powder: 13.2 wt% Honey: 7.7 wt%

【表1】 [Table 1]

【0006】<実施例2>眼の充血や痛みの自覚症状が
あり、点眼薬による治療にもかかわらず症状の改善をみ
ない者7名について、実施例1と同じ組成物を同様に打
錠し、症状に応じて4粒乃至8粒を投与し、その効果を
確認した。その結果を表2に示す。
Example 2 The same composition as in Example 1 was similarly tableted for 7 persons who had subjective symptoms of redness and pain in the eye and did not show improvement in symptoms despite treatment with eye drops. Then, 4 to 8 tablets were administered depending on the symptoms, and the effect was confirmed. The results are shown in Table 2.

【表2】 [Table 2]

【0007】<実施例3>残業を続けると眼のかすみや
痛み或は頭痛や肩こり等の眼精疲労の自覚症状を有し、
点眼薬等による治療にもかかわらず症状の改善をみない
者11名について、実施例1と同じ組成物を同様に打錠
し、症状に応じて4粒乃至10粒を投与し、その効果を
確認した。その結果を表3に示す。
<Example 3> Continuing to work overtime has subjective symptoms of eye strain such as blurred vision and pain, or headache and stiff shoulder.
The same composition as in Example 1 was tabletted in the same manner for 11 persons who did not show improvement in symptoms despite treatment with eye drops and the like, and 4 to 10 tablets were administered depending on the symptoms, and the effect was obtained. confirmed. The results are shown in Table 3.

【表3】 [Table 3]

【0008】<実施例4>仮性近視と診断され、医療機
関における治療にもかかわらず治癒効果の得られない6
名について、実施例1と同じ組成物を同様に打錠し、症
状に応じて4粒乃至12粒を投与し、その効果を確認し
た。その結果を表4に示す。
<Embodiment 4> Pseudo myopia is diagnosed and no curative effect is obtained despite treatment at a medical institution. 6
Regarding the name, the same composition as in Example 1 was tabletted in the same manner, 4 to 12 tablets were administered depending on the symptoms, and the effect was confirmed. The results are shown in Table 4.

【表4】 [Table 4]

【0009】なお、本発明に係る組成物の個々の素材は
それ自体食用等の材料として用いられるものであるか
ら、これらを配合した組成物についてもその副作用につ
いては懸念はないところであるが、念のため上記した実
施例の実施以前に試飲を承諾した健康者43名に実施例
1の錠剤を一日に12粒、90日間にわたり投与した
が、副作用は全く現われなかった。被験者の構成は次の
通りであった。 70歳台:男性2名 60歳台:男性6名 50歳台:男性4名 40歳台:男性13名、女性2名 30歳台:男性12名、女性2名 20歳台:男性1名、女性2名
Since the individual materials of the composition according to the present invention are used as food materials themselves, there is no concern about the side effects of the compositions containing them. For this reason, the 43 tablets of the healthy person who consented to the tasting before the execution of the above-mentioned example were administered 12 tablets of the example 1 for 12 days a day for 90 days, but no side effects appeared. The composition of the subjects was as follows. 70s: 2 males 60s: 6 males 50s: 4 males 40s: 13 males, 2 females 30s: 12 males, 2 females 20s: 1 male , 2 women

【0010】[0010]

【発明の効果】以上説明したように本発明の眼の機能維
持作用及び眼疾患改善作用を有する組成物は、鯉内臓濃
縮物、高麗人参エキス、三七人参、真珠貝粉末、菊花エ
キス、枸杞エキス、ハブ茶エキスを含有しているため、
眼の機能維持に優れた効果があり、しかも副作用がな
い。そのため眼の機能維持効果を有する健康食品などに
用いることが可能である。
Industrial Applicability As described above, the composition of the present invention having the function of maintaining the function of the eye and the effect of improving the eye disease includes carp viscera concentrate, ginseng extract, Radix Notoginseng, pearl oyster powder, chrysanthemum extract, and Fusarium japonica Since it contains extract and hub tea extract,
It has excellent effects on maintaining eye function and has no side effects. Therefore, it can be used as a health food having an effect of maintaining eye function.

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】 鯉内臓濃縮物、高麗人参エキス、三七人
参、真珠貝粉末、菊花エキス、枸杞エキス、ハブ茶エキ
スを含有することを特徴とする眼の機能維持作用及び眼
疾患改善作用を有する組成物。
1. An ocular function-maintaining action and an ocular disease-improving action characterized by containing carp viscera concentrate, Korean ginseng extract, Radix Notoginseng radix, pearl oyster powder, chrysanthemum extract, lacquer extract and hub tea extract. A composition having.
【請求項2】 鯉内臓濃縮物、高麗人参エキス、三七人
参、真珠貝粉末、八つ目鰻エキス、菊花エキス、枸杞エ
キス、ハブ茶エキスを含有することを特徴とする眼の機
能維持作用及び眼疾患改善作用を有する組成物。
2. A function-maintaining action for the eye, which contains carp viscera concentrate, ginseng extract, Radix Notoginseng, pearl oyster powder, eighth eel extract, chrysanthemum extract, lacquer extract and hub tea extract. And a composition having an effect of improving eye diseases.
【請求項3】 小麦胚芽末、蜂蜜の中の1又は2を含有
する請求項1又は2に記載の眼の機能維持作用及び眼疾
患改善作用を有する組成物。
3. The composition having the action of maintaining the function of the eye and the action of improving the eye disease according to claim 1 or 2, which contains wheat germ powder and 1 or 2 of honey.
【請求項4】 鯉内臓濃縮物を5wt%以上15wt%
以下、高麗人参エキスを3wt%以上10wt%以下、
三七人参を5wt%以上15wt%以下、真珠貝粉末を
10wt%以上30wt%以下、八つ目鰻エキスを3w
t%以上10wt%以下、菊花エキスを7wt%以上2
0wt%以下、枸杞エキスを10wt%以上30wt%
以下、ハブ茶エキスを3wt%以上10wt%以下、小
麦胚芽末を8wt%以上25wt%以下、蜂蜜を4wt
%以上12wt%以下、含有する請求項3に記載の眼の
機能維持作用及び眼疾患改善作用を有する組成物。
4. Carp offal concentrate of 5 wt% or more and 15 wt%
Below, ginseng extract is 3 wt% or more and 10 wt% or less,
5% to 15% by weight of Radix Notoginseng, 10% to 30% by weight of pearl oyster powder, 3w of 8th eel extract
t% or more and 10 wt% or less, chrysanthemum extract is 7 wt% or more 2
0 wt% or less, 10% or more and 30 wt% of Pleurotus cornucopia extract
Below, hub tea extract is 3 wt% or more and 10 wt% or less, wheat germ powder is 8 wt% or more and 25 wt% or less, and honey is 4 wt%
% Or more and 12 wt% or less, The composition having an ocular function maintaining action and an eye disease improving action according to claim 3.
JP3106637A 1991-04-10 1991-04-10 Composition having action to maintain ophthalmic function and to remit ophthalmic disease Pending JPH0597690A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3106637A JPH0597690A (en) 1991-04-10 1991-04-10 Composition having action to maintain ophthalmic function and to remit ophthalmic disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3106637A JPH0597690A (en) 1991-04-10 1991-04-10 Composition having action to maintain ophthalmic function and to remit ophthalmic disease

Publications (1)

Publication Number Publication Date
JPH0597690A true JPH0597690A (en) 1993-04-20

Family

ID=14438633

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3106637A Pending JPH0597690A (en) 1991-04-10 1991-04-10 Composition having action to maintain ophthalmic function and to remit ophthalmic disease

Country Status (1)

Country Link
JP (1) JPH0597690A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020035200A (en) * 2000-11-04 2002-05-11 유종구 Manufacturing method of eyewash for class of shell
WO2003013556A1 (en) * 2001-08-02 2003-02-20 Chiduko Yamagami Medicinal compositions having effects of ameliorating eye diseases and holding eye functions
CN1303919C (en) * 2003-01-15 2007-03-14 倪龙 Health-care preparation containing pearl and ginseng active components
EP2186424A1 (en) * 2008-11-13 2010-05-19 Unilever N.V. Process for preparing a natural extract
CN102648968A (en) * 2011-02-26 2012-08-29 晏素琼 External traditional Chinese medicine composition for eye health
CN103127233A (en) * 2013-02-27 2013-06-05 尹梦竹 Traditional Chinese medicine for treating eye diseases, and its production method
CN104027651A (en) * 2014-06-27 2014-09-10 郑增友 Eye drops for treating eye diseases
CN104547024A (en) * 2015-01-19 2015-04-29 耿建芳 Medicine for treating trachoma
JP2021505650A (en) * 2017-12-04 2021-02-18 中国▲薬▼科大学China Pharmaceutical University Ophthalmic drug preparations and their use
CN112402352A (en) * 2020-12-10 2021-02-26 杭州宝尔科技有限公司 Health-care beauty eye cream for relieving asthenopia and preventing deepening of degrees

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020035200A (en) * 2000-11-04 2002-05-11 유종구 Manufacturing method of eyewash for class of shell
WO2003013556A1 (en) * 2001-08-02 2003-02-20 Chiduko Yamagami Medicinal compositions having effects of ameliorating eye diseases and holding eye functions
CN1303919C (en) * 2003-01-15 2007-03-14 倪龙 Health-care preparation containing pearl and ginseng active components
EP2186424A1 (en) * 2008-11-13 2010-05-19 Unilever N.V. Process for preparing a natural extract
CN102648968A (en) * 2011-02-26 2012-08-29 晏素琼 External traditional Chinese medicine composition for eye health
CN103127233A (en) * 2013-02-27 2013-06-05 尹梦竹 Traditional Chinese medicine for treating eye diseases, and its production method
CN104027651A (en) * 2014-06-27 2014-09-10 郑增友 Eye drops for treating eye diseases
CN104547024A (en) * 2015-01-19 2015-04-29 耿建芳 Medicine for treating trachoma
JP2021505650A (en) * 2017-12-04 2021-02-18 中国▲薬▼科大学China Pharmaceutical University Ophthalmic drug preparations and their use
CN112402352A (en) * 2020-12-10 2021-02-26 杭州宝尔科技有限公司 Health-care beauty eye cream for relieving asthenopia and preventing deepening of degrees

Similar Documents

Publication Publication Date Title
CN102178784B (en) Combination therapy used for treating visual disturbances and damages and relieving asthenopia
JPH0597690A (en) Composition having action to maintain ophthalmic function and to remit ophthalmic disease
CN109430856A (en) A kind of eye-protecting improves the Ricipe for health care food and preparation method thereof of visual fatigue
JP2002017295A (en) Health auxiliary food product having activity for ameliorating eye disease and activity for keeping function of eye
CN108853356A (en) A kind of man is delayed spray and preparation method thereof
CN104606615A (en) Traditional Chinese medicine eyedrop for treating ocular inflammation and preparation method thereof
CN110859895A (en) Eye ointment and preparation method thereof
JPH0597691A (en) Composition having action to remit ophthalmic disease and to maintain ophthalmic function
CN1498633A (en) Oral liquid for treating ophthalmic diseases
CN1037237C (en) &#34;Qianliming&#34; oculentum
CN103948866A (en) Chinese medicinal decoction for treating acute iridocyclitis and preparation method of Chinese medicinal decoction
CN106620278A (en) Bacteriostatic traditional Chinese medicinal eye drops as well as preparation method and application thereof
CN112755146A (en) Citron and fingered citron liver soothing cream and preparation method thereof
JP3103396B2 (en) Bath agent
CN111228408A (en) Penis cervi, ginseng and oyster soft capsule for enhancing male sexual function and preparation method thereof
CN104523981A (en) Traditional Chinese medicine preparation for treating optic neuritis and preparation method
CN103948633A (en) Eye drops for treating oculopathy and preparation method thereof
RU2033798C1 (en) Agent for apitherapy and apiprophylaxis
CN108991364A (en) A kind of black pine novel foodstuff and preparation method thereof
CN105876044A (en) Beauty maintaining chocolate
CN107684565A (en) A kind of medicine for treating blood-shoot-eye illness and preparation method thereof
JP2001316279A (en) Composition for fatigue recovery
RU2161038C1 (en) Medicinal species for alcohol withdrawal syndrome and alcohol addiction elimination
BG2526U1 (en) A means for increasing sexual activity
JP2023532152A (en) Drug composition for treating or reducing alcohol hangover and use thereof